11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
Items 201–300 of 1,000
Hexose-6-phosphate dehydrogenase in the endoplasmic reticulum
Senesi, S., Csala, M., Marcolongo, P., Fulceri, R., Mandl, J., Bánhegyi, G., & Benedetti, A. (2009) · Biological Chemistry · doi:10.1515/bc.2009.146 · Cited by 64
Esche, J., Shi, L., Sánchez‐Guijo, A., Hartmann, M. F., Wudy, S. A., & Remer, T. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.033 · Cited by 69
Ashraf, S. A., Elkhalifa, A. E. O., Mehmood, K., Adnan, M., Khan, M. A., Eltoum, N. E., Krishnan, A., & Baig, M. S. (2021) · Molecules · doi:10.3390/molecules26195957 · Cited by 67
Identification of 11β-HSD1 inhibitors through enhanced sampling methods
Singh, R., Bhardwaj, V. K., Das, P., & Purohit, R. (2022) · Chemical Communications · doi:10.1039/d1cc06894f · Cited by 63
Walker, E. A., Ahmed, A., Lavery, G. G., Tomlinson, J. W., Kim, S. Y., Cooper, M. S., Ride, J. P., Hughes, B. A., Shackleton, C. H. L., McKiernan, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704144200 · Cited by 59
Self-citationHornby, C., Botfield, H. F., O’Reilly, M., Westgate, C. S. J., Mitchell, J., Mollan, S. P., Manolopoulos, K. N., Tomlinson, J., & Sinclair, A. J. (2017) · Neuro-Ophthalmology · doi:10.1080/01658107.2017.1334218 · Cited by 64
Self-citationGatti, R., Cappellin, E., Zecchin, B., Antonelli, G., Spinella, P., Mantero, F., & Palo, E. F. D. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.06.037 · Cited by 62
Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014934108 · Cited by 61
Self-citationScott, J. S., Bowker, S. S., deSchoolmeester, J., Gerhardt, S., Hargreaves, D., Kilgour, E., Lloyd, A., Mayers, R. M., McCoull, W., Newcombe, N. J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300592r · Cited by 61
Ge, R., Dong, Q. G., Sottas, C. M., Latif, S. A., Morris, D. J., & Hardy, M. P. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.08.004 · Cited by 65
Charmandari, E., & Kino, T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02336.x · Cited by 61
Bhat, B. G., Hosea, N. A., Fanjul, A. N., Herrera, J., Chapman, J., Thalacker, F. W., Stewart, P. M., & Rejto, P. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128280 · Cited by 65
Self-citationInsulin and Dexamethasone Dynamically Regulate Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1
Balachandran, A., Guan, H., Sellan, M. E., Uum, S. H. M. V., & Yang, K. (2008) · Endocrinology · doi:10.1210/en.2008-0088 · Cited by 68
Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator
Xu, Z., Zhao, F., Lin, F., Xiang, H., Wang, N., Ye, D., & Huang, Y. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.03.056 · Cited by 63
Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
Legeza, B., Marcolongo, P., Gamberucci, A., Varga, V., Bánhegyi, G., Benedetti, A., & Odermatt, A. (2017) · Nutrients · doi:10.3390/nu9050426 · Cited by 66
Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
Darmon, P., Dadoun, F., Boullu-Ciocca, S., Grino, M., Alessi, M.-C., & Dutour, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00654.2005 · Cited by 59
Tokarz, J., Norton, W., Möller, G., de Angelis, M. H., & Adamski, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054851 · Cited by 68
“In humans, 11b-HSD type 1 catalyzes the reactivation of cortisone to cortisol [48,49].”
Stomby, A., Andrew, R., Walker, B. R., & Olsson, T. (2014) · Diabetologia · doi:10.1007/s00125-014-3228-6 · Cited by 68
Feraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 60
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 60
Guo, C., Li, C., Myatt, L., Nathanielsz, P. W., & Sun, K. (2013) · Diabetes · doi:10.2337/db12-0561 · Cited by 57
“11b-HSD1 is a bidirectional enzyme capable of both reductase and oxidase activity (15).”
Recent advances in 17beta-hydroxysteroid dehydrogenases
Prehn, C. P., Möller, G., & Adamski, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.024 · Cited by 63
Lactational Programming of Infant Behavioral Phenotype
Hinde, K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4060-4_9 · Cited by 65
“…activity and distribution of 11 b -hydroxy-steroid dehydrogenases , enzymes that either inactivate (11 b -HSD1) or enhance (11 b -HSD2) the physiological effects of glucocorticoids (Seckl 2004 ; Tomlinson et al. 2004 ) , are different in rat pups before and after weaning (Pácha and Miksík 1996 ) .”
Bremer, A. A., & Miller, W. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00013-5 · Cited by 70
Nakajima, S., Koh, V., Kua, L.-F., So, J., Davide, L., Lim, K. S., Petersen, S. H., Yong, W.-P., Shabbir, A., & Kono, K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600895 · Cited by 55
“11b-HSD1 converts intracellular cortisone to cortisol, which activates GR and downstream signaling (38).”
Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review
Alam, J., & Sharma, L. K. (2018) · Current Drug Targets · doi:10.2174/1389450119666180820104723 · Cited by 58
Modulation of glucocorticoid action and the treatment of type-2 diabetes
Tomlinson, J., & Stewart, P. M. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.07.003 · Cited by 59
Self-citationIwasaki, Y., Takayasu, S., Nishiyama, M., Tsugita, M., Taguchi, T., Asai, M., Yoshida, M., Kambayashi, M., & Hashimoto, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.012 · Cited by 60
“…TNF and insulin are nown to activate AP1 transcription factors via protein phoshorylation as well as protein induction (Griffiths et al., 1998; entura et al., 2003), which may explain the transcriptional synrgism between the adipokine and insulin observed in this study. ince there are other…”
Hwang, J.-Y., Lee, S. H., Kim, G. S., Koh, J.-M., Go, M. J., Kim, Y.-J., Kim, H.-C., Kim, T.-H., Hong, J. M., Park, E. K., et al. (2009) · Bone · doi:10.1016/j.bone.2009.07.080 · Cited by 55
Wake, D. J., Homer, N. Z. M., Andrew, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0819 · Cited by 57
Candia, R., Riquelme, A., Baudrand, R., Carvajal, C. A., Morales, M., Solís, N., Pizarro, M., Escalona, A., Carrasco, G., Boza, C., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02685.x · Cited by 54
Li, W., Gao, L., Wang, Y., Duan, T., Myatt, L., & Sun, K. (2006) · Endocrinology · doi:10.1210/en.2005-1626 · Cited by 54
Latif, S. A., Pardo, H. A., Hardy, M. P., & Morris, D. J. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.08.006 · Cited by 54
The inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substances
Zhao, B., Lian, Q., Chu, Y., Hardy, D. O., Li, X., & Ge, R. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.017 · Cited by 54
Hintzpeter, J., Stapelfeld, C., Loerz, C., Martin, H.-J., & Maser, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084468 · Cited by 53
Teofilović, A., Bursać, B. N., Djordjevic, A. D., Milutinović, D. V., Nikolič, M., Matić, G. M., & Veličković, N. A. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0641-4 · Cited by 56
Jun, H. S., Lee, Y., Song, K., Mansfield, B. C., & CHOU, J. Y. (2011) · Blood · doi:10.1182/blood-2010-08-302059 · Cited by 53
Ignatova, I. D., Kostadinova, R. M., Goldring, C. E., Nawrocki, A. R., Frey, F. J., & Frey, B. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90531.2008 · Cited by 61
Aging increases basal but not stress-induced levels of corticosterone in the brain of the awake rat
Garrido, P., de Blas, M., Arco, A. D., Segovia, G., & Mora, F. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.015 · Cited by 61
Morris, D. J., Latif, S., Hardy, M. P., & Brem, A. S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.020 · Cited by 58
Primary Generalized Glucocorticoid Resistance and Hypersensitivity
Charmandari, E. (2011) · Hormone Research in Paediatrics · doi:10.1159/000330759 · Cited by 52
“This variable clinical phenotype is due to variations in the tissue sensitivity of the glucocorticoid, mineralocorticoid and/or androgen receptor signaling pathways; variations in the activity of key hormone-inactivating or hormone-activating enzymes, such as 11β-hydroxysteroid dehydrogenase [”
Classen-Houben, D., Schuster, D., Cunha, T. D., Odermatt, A., Wolber, G., Jordis, U., & Kueenburg, B. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.01.009 · Cited by 56
Semjonous, N. M., Sherlock, M., Jeyasuria, P., Parker, K. L., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2011) · Endocrinology · doi:10.1210/en.2010-0957 · Cited by 51
Self-citationWalker, B. R. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s002966510700523x · Cited by 54
“Regulation of 11b-hydroxysteroid dehydrogenase type 1 A wide variety of factors are known to regulate 11b-HSD1 mRNA levels and activity in rodents and in isolated cells in culture (for review, see Tomlinson et al. 2004b).”
Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum
Bánhegyi, G., Csala, M., & Benedetti, A. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0156 · Cited by 55
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Corticosteroids, 11β‐Hydroxysteroid Dehydrogenase Isozymes and the Rabbit Choroid Plexus
Sinclair, A. J., Onyimba, C., Khosla, P., Vijapurapu, N., Tomlinson, J., Burdon, M., Stewart, P., Murray, P. I., Walker, E. A., & Rauz, S. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01569.x · Cited by 54
Self-citationMohler, E. G., Browman, K. E., Roderwald, V. A., Cronin, E. A., Markosyan, S., Bitner, R. S., Strakhova, M. I., Drescher, K. U., Hornberger, W., Rohde, J. J., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4046-10.2011 · Cited by 53
Idiopathic intracranial hypertension, hormones, and 11ß-hydroxysteroid dehydrogenases
Sinclair, A. J., Markey, K. A., Uldall, M., Cato, L. D., Miah, M. S., Botfield, H. F., Gonzalez, A. M., Jensen, R., & Hassan‐Smith, G. (2016) · Journal of Pain Research · doi:10.2147/jpr.s80824 · Cited by 72
Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor
Cohen, D. M., & Steger, D. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.04.001 · Cited by 46
“Through distinct tissue-specific expression profiles, they amplify or mute responses to the circulating cortisol level set by the HPA axis [22].”
Lavery, G. G., Idkowiak, J., Sherlock, M., Bujalska, I., Ride, J. P., Saqib, K., Hartmann, M. F., Hughes, B., Wudy, S. A., De Schepper, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0628 · Cited by 50
Self-citationSultan, A., Strodthoff, D., Robertson, A.-K., Paulsson-Berne, G., Fauconnier, J., Parini, P., Rydén, M., Thierry-Mieg, N., Johansson, M. E., Chibalin, A. V., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190280 · Cited by 50
Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells
Ahasan, M. M., Hardy, R., Jones, C., Kaur, K., Nanus, D., Juarez, M., Morgan, S. A., Hassan‐Smith, Z., Bénézech, C., Caamaño, J. H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34414 · Cited by 49
Self-citationIncreased glucocorticoid activation during mouse skin wound healing
Tiganescu, A., Hupe, M., Uchida, Y., Mauro, T. M., Elias, P. M., & Holleran, W. M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0420 · Cited by 53
“11b-HSD1 is ubiquitously expressed with well-defined physiological and pathological roles in the liver, brain, muscle, bone, and adipose tissue (Tomlinson et al. 2004, Cooper & Stewart 2009).”
11β-HSD1 in Human Fetal Membranes as a Potential Therapeutic Target for Preterm Birth
Wang, W., Chen, Z., Myatt, L., & Sun, K. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00188 · Cited by 52
St‐Pierre, J., Laplante, D. P., Elgbeili, G., Dawson, P. A., Kildea, S. V., King, S., & Vaillancourt, C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.04.027 · Cited by 50
Liu, J., Xie, Y., Cooper, R., Ducharme, D. M. K., Tennant, R. W., Diwan, B. A., & Waalkes, M. P. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.01.018 · Cited by 50
The Stress Axis in Obesity and Diabetes Mellitus: An Update
Gianotti, L., Belcastro, S., D’Agnano, S., & Tassone, F. (2021) · Endocrines · doi:10.3390/endocrines2030031 · Cited by 59
“Conversely 11β-HSD2 is a high-affinity NAD-dependent dehydrogenase which inactivates cortisol, protecting the non-selective mineralocorticoid receptor in the kidney and colon from cortisol excess [27].”
Hou, M., Liu, Y., Zhu, L., Sun, B., Guo, M., Burén, J., & Li, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025726 · Cited by 57
Thoeringer, C. K., Sillaber, I., Roedel, A., Erhardt, A., Mueller, M. B., Ohl, F., Holsboer, F., & Keck, M. E. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.005 · Cited by 55
Cooper, M. S., Syddall, H. E., Fall, C. H. D., Wood, P. J., Stewart, P. M., Cooper, C., & Dennison, E. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02281.x · Cited by 48
Self-citationBriassoulis, G., Damjanovic, S., Xekouki, P., Lefebvre, H., & Stratakis, C. A. (2011) · Endocrine Practice · doi:10.4158/ep11061.ra · Cited by 48
“Accordingly, several mechanisms have been postulated for tissuespecific regulation of glucocorticoid actions, from different metabolism of the ligands (4) to HEXIM1-mediated repression of GR (5).”
Tokarz, J., Mindnich, R., Norton, W., Möller, G., Hrabé de Angelis, M., & Adamski, J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.022 · Cited by 48
“11beta-HSD type 2 catalyzes the inactivation of cortisol to cortisone, while 11beta-HSD type 1 is responsible for local production of the potent hormone cortisol enhancing glucocorticoid receptor activation (Tomlinson et al., 2004).”
Hussan, F., Mansor, A. S., Hassan, S. N., Kamaruddin, T. N. T. T. N. E., Budin, S. B., & Othman, F. B. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/347861 · Cited by 48
Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue
Bursać, B. N., Djordjevic, A. D., Teofilović, A., Milutinović, D. V., Veličković, N. A., Nestorović, N. M., & Matić, G. M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.09.002 · Cited by 50
Genomic variants in polycystic ovary syndrome
Luque‐Ramírez, M., Millán, J. L. S., & Escobar-Morreale, H. F. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.017 · Cited by 54
Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism
White, P. C., Rogoff, D., McMillan, D. R., & Lavery, G. G. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.022 · Cited by 50
“These studies have identified 11-HSD1 as a promising drug target for treating the metabolic syndrome (including type 2 diabetes) associated with obesity in humans (Tomlinson et al., 2004).”
Self-citationWhite, P. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0942 · Cited by 47
Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases
Kang, J., Asai, D., & Toita, R. (2023) · Journal of Xenobiotics · doi:10.3390/jox13040049 · Cited by 70
Pang, S., Wu, H., Wang, Q., Cai, M., Shi, W., & Shang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098283 · Cited by 47
Transcriptional analysis of endocrine disruption using zebrafish and massively parallel sequencing
Baker, M. E., & Hardiman, G. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0219 · Cited by 53
“However, MR also is important in other organs such as heart and brain, in which the MR may be activated by aldosterone or cortisol (Funder 2009; Tomlinson et al. 2004).”
Siu, M., Johnson, T., Wang, Y., Nair, S. K., Taylor, W. D., Cripps, S. J., Matthews, J. J., Edwards, M. P., Pauly, T. A., Ermolieff, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.011 · Cited by 47
Clinical and Basic Aspects of Glucocorticoid Action in Bone
Kream, B. E., Graves, L., & Lukert, B. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00061-6 · Cited by 47
Ragnarsson, O., Mattsson, A. F., Monson, J. P., Filipsson Nyström, H., Åkerblad, A.-C., Kołtowska-Häggström, M., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0397 · Cited by 46
Osteoblastic glucocorticoid signaling exacerbates high-fat-diet- induced bone loss and obesity
Kim, S., Henneicke, H., Cavanagh, L. L., Macfarlane, E., Thai, L. J., Foong, D., Gasparini, S. J., Fong-Yee, C., Swarbrick, M. M., Seibel, M. J., et al. (2021) · Bone Research · doi:10.1038/s41413-021-00159-9 · Cited by 46
Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for hypertension
Hunter, R. W., & Bailey, M. A. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.01.005 · Cited by 51
Bis-aryl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1
Aster, S. D., Graham, D. W., Kharbanda, D., Patel, G. F., Ponpipom, M. M., Santorelli, G. M., Szymonifka, M. J., Mundt, S. S., Shah, K., Springer, M. S., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.010 · Cited by 47
Campino, C., Carvajal, C. A., Cornejo, J., Martín, B. S., Olivieri, O., Guidi, G. C., Faccini, G., Pasini, F., Sateler, J., Baudrand, R. F., et al. (2009) · Endocrine · doi:10.1007/s12020-009-9269-9 · Cited by 48
Glucocorticoid Effects on Adiponectin Expression
Sukumaran, S., DuBois, D. C., Jusko, W. J., & Almon, R. R. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-398313-8.00007-5 · Cited by 49
Dekker, M. J. H. J., Tiemeier, H., Luijendijk, H. J., Kuningas, M., Hofman, A., de Jong, F. H., Stewart, P. M., Koper, J. W., & Lamberts, S. W. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0601 · Cited by 46
Self-citationHardy, R., & Cooper, M. S. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.007 · Cited by 52
Self-citationThe hypothalamic–pituitary–adrenal axis in critical illness
Venkataraman, S. T., Munoz, R. A., Cândido, C., & Witchel, S. F. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9058-9 · Cited by 51
“The 11β-hydroxysteroid dehydrogenase type 1 enzyme acts primarily as an oxoreductase to convert inactive cortisone to active cortisol [ 7 ].”
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Self-citationAdrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Stress, glucocorticoid signaling pathway, and metabolic disorders
de Guia, R. M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.038 · Cited by 48
Glucocorticoid-Induced osteoporosis: clinical and therapeutic aspects
Mazziotti, G., Giustina, A., CANALIS, E. M., & Bilezikian, J. P. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800028 · Cited by 54
“This enzyme system therefore plays a critical role in the regulation of glucocorticoid activity (52).”
Zhang, T. Y., & Daynes, R. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6325 · Cited by 45
Baudrand, R. F., Campino, C., Carvajal, C. A., Olivieri, O., Guidi, G. C., Faccini, G., Sateler, J., Cornejo, J., Martín, B. S., Domínguez, J. M., et al. (2011) · Steroids · doi:10.1016/j.steroids.2011.09.010 · Cited by 48
Effect of dehydroepiandrosterone on the immune function of mice in vivo and in vitro
Cao, J., Yu, L., Zhao, J., & Ma, H. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.06.004 · Cited by 44
Scott, J. S., deSchoolmeester, J., Kilgour, E., Mayers, R. M., Packer, M. J., Hargreaves, D., Gerhardt, S., Ogg, D., Rees, A., Selmi, N., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301252n · Cited by 44
Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis
Hardy, R., Juárez, M., Naylor, A. J., Tu, J., Rabbitt, E. H., Filer, A. D., Stewart, P. M., Buckley, C. D., Raza, K., & Cooper, M. S. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4065 · Cited by 48
Self-citationHepatic 11beta‐HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis
Konopelska, S., Kienitz, T., Hughes, B., Pirlich, M., Bauditz, J., Lochs, H., Strasburger, C. J., Stewart, P. M., & Quinkler, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03358.x · Cited by 41
Self-citationCortisol Biosynthesis in the Human Ocular Surface Innate Immune Response
Susarla, R., Liu, L., Walker, E. A., Bujalska, I. J., Al-Salem, J. A., Williams, G. P., Sreekantam, S., TAYLOR, A. E. R., Tallouzi, M., Southworth, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094913 · Cited by 43
Self-citationAcute Stress Assessment From Excess Cortisol Secretion: Fundamentals and Perspectives
Boucher, P., & Plusquellec, P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00749 · Cited by 44
Thieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 48
Raffaelli, A., Saba, A., Vignali, E., Marcocci, C., & Salvadori, P. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.11.011 · Cited by 46
Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients
Hoshiro, M., Ohno, Y., Masaki, H., Iwase, H., & Aoki, N. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02412.x · Cited by 44
Daniels, G. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00002-x · Cited by 42
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Bavaresco, A., Mazzeo, P., Lazzara, M., & Barbot, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116137 · Cited by 45
Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats
Zhao, M., Li, Y., Wang, J., Ebihara, K., Rong, X., Hosoda, K., Tomita, T., & Nakao, K. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01471.x · Cited by 42
“The adipose enzyme, 11 β -HSD1, which locally converts inactive glucocorticoids into bioactive forms [18], plays an important role in the development of visceral obesity and its associated metabolic disturbances [19–22].”
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.